<DOC>
	<DOC>NCT00441493</DOC>
	<brief_summary>This is a dose finding and efficacy trial for fluvastatin versus hepatitis C.</brief_summary>
	<brief_title>Fluvastatin Versus Hepatitis C Virus</brief_title>
	<detailed_description>Four different oral doses of fluvastatin will be used for 14 days and the viral load of hepatitis C will be measured weekly. This has been extended to different doses for 9-12 weeks.</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>HCV RNA positive Testing positive for alcohol or marijuana</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>fluvastatin</keyword>
</DOC>